Search

Codexis Inc

Gesloten

SectorGezondheidszorg

1.32 -2.94

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.32

Max

1.3900000000000001

Belangrijke statistieken

By Trading Economics

Inkomsten

-3.3M

-12M

Verkoop

-333K

15M

EPS

-0.13

Winstmarge

-80.489

Werknemers

146

EBITDA

-4.3M

-11M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+374.45% upside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-10M

151M

Vorige openingsprijs

4.26

Vorige sluitingsprijs

1.32

Nieuwssentiment

By Acuity

45%

55%

104 / 339 Rangschikking in Healthcare

Codexis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 sep 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a decline since Wednesday and closing below its 20-day moving average near the lower end of its one-month range.

23 sep 2026, 20:07 UTC

Codexis Inc shares fell as concerns about inflation and rising bond yields weighed on investor sentiment, pulling back after an earlier session rebound.

22 sep 2026, 20:01 UTC

Codexis Inc shares are up significantly in the current session, marking the third consecutive day of gains, despite remaining below the 20-day moving average.

18 sep 2026, 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

17 sep 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a trend of three consecutive sessions lower, with the current price significantly below its 20-day moving average.

16 sep 2026, 19:22 UTC

Codexis Inc shares fell sharply amid a broader market downturn, pressured by rising U.S. Treasury yields and inflation concerns following strong retail sales data.

15 sep 2026, 20:01 UTC

Codexis Inc shares are trading lower as the NY Empire State Manufacturing Index fell to 7.6 in September, raising concerns about economic contraction.

4 sep 2026, 19:51 UTC

Codexis Inc shares are higher during Friday's session amid market volatility, reflecting a notable early-session gain despite recent declines and no specific news.

3 sep 2026, 20:07 UTC

Codexis Inc shares are lower during Thursday's session, marking four consecutive days of declines amid broader market weakness and rising jobless claims.

1 sep 2026, 20:01 UTC

Codexis Inc shares are lower amid broader market concerns over rising oil prices and inflation, with no specific news identified to explain the decline.

31 aug 2026, 20:02 UTC

Codexis Inc is gaining during Monday's session, despite an earlier pullback. Broader market conditions reflect heightened expectations for potential interest rate hikes.

28 aug 2026, 19:51 UTC

Codexis Inc. shares are trading lower today, having peaked earlier in the session before declining significantly. No specific news has been identified.

27 aug 2026, 20:07 UTC

Codexis Inc. shares are trading roughly flat amid minimal market movement. The stock remains above its 20-day moving average and near its one-month range.

26 aug 2026, 19:56 UTC

Codexis Inc. shares are lower today, reflecting a broader downward trend amid persistent inflationary pressures impacting market sentiment.

24 aug 2026, 19:16 UTC

Codexis Inc. shares are trading higher during Monday's session, with market focus on upcoming macroeconomic developments, including a speech by Federal Reserve Chair Kevin Warsh.

21 aug 2026, 19:46 UTC

Correlated Moves

Codexis Inc shares are higher today, reflecting strong momentum. This aligns with a broader biotechnology trend, supported by gains in the ARK Genomic Revolution ETF.

20 aug 2026, 19:16 UTC

Codexis Inc. shares are roughly flat as no specific news emerged. Intraday fluctuations ranged from a high of 8.23% to a low of -1.27%.

19 aug 2026, 20:02 UTC

Correlated Moves
News

Codexis Inc shares are higher today, supported by positive momentum in the genomics sector and the performance of the ARK Genomic Revolution ETF.

18 aug 2026, 19:41 UTC

Codexis Inc shares are trading lower during Tuesday's session, continuing a decline since Monday's close amid broader market concerns over rising treasury yields and inflation.

17 aug 2026, 19:56 UTC

News

Codexis shares are higher as Piper Sandler maintains Overweight rating and lowers price target to $8.00 from $9.00. Positive investor sentiment persists.

14 aug 2026, 19:46 UTC

Codexis Inc shares are lower, reflecting broader market weakness amid an unexpected decline in U.S. retail sales for July.

13 aug 2026, 19:51 UTC

News

Codexis reported Q2 2026 revenue of $14.9 million and a net loss of $12.0 million. Shares are trading roughly flat during Thursday's session.

12 aug 2026, 20:01 UTC

News

Codexis reported a narrower net loss of $12 million and reaffirmed revenue guidance of $72 million to $76 million, contributing to gains during Wednesday's session.

11 aug 2026, 23:51 UTC

News

Codexis reported second-quarter revenues of $14.9 million, exceeding estimates. Shares are trading higher in after-market hours following the positive earnings report and guidance.

10 aug 2026, 19:21 UTC

News

Codexis Inc shares are higher following a positive earnings report, with a loss per share of -$0.10, better than analysts' expectations of -$0.11.

7 aug 2026, 19:36 UTC

Codexis Inc shares are lower, reflecting broader market trends amid uncertainty over monetary policy and a weaker-than-expected jobs report.

6 aug 2026, 19:56 UTC

Codexis Inc shares are higher during Thursday's session, continuing an upward trend. The stock remains below its 20-day moving average.

5 aug 2026, 20:06 UTC

Codexis Inc shares are higher today, reflecting positive market sentiment amid a broader uptick in equities. No specific news was identified for the movement.

4 aug 2026, 19:56 UTC

Codexis Inc. shares are trading roughly flat, with no specific news identified. The stock remains below its 20-day moving average and near its one-month range low.

3 aug 2026, 19:44 UTC

News

Codexis Inc has appointed David Butler, PhD, to its Strategic Advisory Board. Shares are advancing, though still below the 20-day moving average.

Peer Vergelijking

Prijswijziging

Codexis Inc Prognose

Koersdoel

By TipRanks

374.45% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.5 USD  374.45%

Hoogste 11 USD

Laagste 2 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Codexis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Sentiment

By Acuity

104 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.